Australia TGA ARTG recordNeedle, hypodermic
Australia TGA ARTG Registered Device · Abbvie Pty Ltd · TSK Laboratory Japan · Class IIa · Started December 16, 2011
Good Name: Abbvie Pty Ltd - Needle, hypodermic
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- December 16, 2011
- Effective Date
- December 16, 2011
- Name
- Abbvie Pty Ltd
- Country
- Japan
- Address
- 1510-1 Soja-Machi, Tochigi-Shi, Tochigi-Ken, 328-0002
Hypodermic needles are intended for injection or withdrawing fluid with syringe or other devices.
Access comprehensive regulatory information for Needle, hypodermic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Abbvie Pty Ltd, manufactured by TSK Laboratory Japan in Japan. The device registration started on December 16, 2011.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.